Regulatory Considerations for Combined Drug-Device Studies in Europe: A Case Study Involving Bile Sampling

Hans-Peter Podhaisky, Emiko Tsuruta, Isabel Piel, Christiane Otto, Sofia Busto Paez, Miriam Font-Nieves

Open source

DOI
10.1007/s40290-026-00619-9
Published
2026-07-03
Container
Pharmaceutical Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40290-026-00619-9,
  title = {Regulatory Considerations for Combined Drug-Device Studies in Europe: A Case Study Involving Bile Sampling},
  author = {Hans-Peter Podhaisky and Emiko Tsuruta and Isabel Piel and Christiane Otto and Sofia Busto Paez and Miriam Font-Nieves},
  year = {2026},
  journal = {Pharmaceutical Medicine},
  doi = {10.1007/s40290-026-00619-9},
  url = {https://doi.org/10.1007/s40290-026-00619-9}
}

RIS

TY  - JOUR
TI  - Regulatory Considerations for Combined Drug-Device Studies in Europe: A Case Study Involving Bile Sampling
AU  - Hans-Peter Podhaisky
AU  - Emiko Tsuruta
AU  - Isabel Piel
AU  - Christiane Otto
AU  - Sofia Busto Paez
AU  - Miriam Font-Nieves
PY  - 2026
JO  - Pharmaceutical Medicine
DO  - 10.1007/s40290-026-00619-9
UR  - https://doi.org/10.1007/s40290-026-00619-9
ER  - 

APA

Podhaisky, H., Tsuruta, E., Piel, I., Otto, C., Paez, S. B., & Font-Nieves, M. (2026). Regulatory Considerations for Combined Drug-Device Studies in Europe: A Case Study Involving Bile Sampling. Pharmaceutical Medicine. https://doi.org/10.1007/s40290-026-00619-9

Source records